Insulin Glargine and Lixisenatide Injection（Ⅰ）

Sanofi KK🇨🇳 National Medical Products Administration

Approval Id: 7a5a50df16539ea3
Approval Number: 国药准字SJ20230001
Generic Name: 甘精胰岛素利司那肽注射液(Ⅰ)
Generic Name En: Insulin Glargine and Lixisenatide Injection（Ⅰ）
Trade Name: 赛益宁
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 预填充笔，3ml：300单位甘精胰岛素 + 300 μg利司那肽
Reg Date: 2023-01-10
Expired Date: 2028-01-09
Company Name: Sanofi KK
Production Company Name: Sanofi-Aventis Deutschland Gmbh
Company Detail Path: /organization/sanofi-kk
Production Company Detail Path: /organization/sanofi-aventis-deutschland-gmbh

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Jan 10, 2023

Approval ID

7a5a50df16539ea3

Type

生物制品